Lamotrigine combined with Lyrica

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Drug Eruption Hospitalization 10/1/2004 37 Female 137 lb 5/25/2006 Physician Germany
Primary
Concomitant
Disorientation Other Serious 7/10/2005 77 Male 5/25/2006 Other Health Professional United Kingdom
Primary
Concomitant
Vision Blurred Other Serious 7/1/2006 36 Male 8/11/2006 France
Primary
Concomitant
Ectopic Pregnancy Other Serious 37 Female 10/10/2006 Other Health Professional United States
Primary
Concomitant
Sleep Disorder Hospitalization 9/7/2006 85 Female 150 lb 12/6/2006 Other Health Professional France
Primary
Concomitant
Somnolence Hospitalization 9/12/2006 74 Male 209 lb 12/6/2006 Other Health Professional France
Primary
Concomitant
Unevaluable Event Other Serious 11/5/2006 Male 156 lb 2/12/2007 Physician France
Primary
Concomitant
Tachyarrhythmia Other Serious 29 Male 154 lb 3/1/2007 Other Health Professional United Kingdom
Primary
Concomitant
Myalgia Other Serious 1/1/2007 69 Male 3/16/2007 Physician France
Primary
Concomitant
Status Epilepticus Hospitalization Female 3/21/2007 Other Health Professional Germany
Primary
Concomitant
Urinary Retention Other Serious 29 Male 4/18/2007 United Kingdom
Primary
Secondary
Urinary Retention Other Serious 29 Male 5/2/2007 United Kingdom
Primary
Secondary
Postictal State Hospitalization 46 Male 6/22/2007 Other Health Professional United Kingdom
Primary
Concomitant
Vith Nerve Paralysis Disability 4/18/2007 Female 6/25/2007 Physician Germany
Primary
Concomitant
Vith Nerve Paralysis Other Serious 1/1/2007 Female 8/6/2007 Physician Germany
Primary
Concomitant
Ventricular Septal Defect Other Serious Female 9/24/2007 Physician Belgium
Primary
Secondary
Pelvic Venous Thrombosis Life Threatening 9/13/2007 Female 209 lb 9/27/2007 Germany
Primary
Secondary
Concomitant
Weight Increased Other Serious 36 Female 10/2/2007 Physician Czech Republic
Primary
Concomitant
Pelvic Venous Thrombosis Life Threatening 9/13/2007 Female 209 lb 10/2/2007 Germany
Primary
Secondary
Concomitant
Pelvic Venous Thrombosis Life Threatening 9/10/2007 Female 209 lb 10/8/2007 Germany
Primary
Secondary
Concomitant
Pelvic Venous Thrombosis Life Threatening 9/10/2007 Female 209 lb 10/23/2007 Germany
Primary
Secondary
Concomitant
Vision Blurred Other Serious 44 Female 11/1/2007 Consumer Germany
Primary
Concomitant
Unevaluable Event Other Serious Female 12/7/2007 Physician Germany
Primary
Concomitant
Suicide Attempt Hospitalization 10/15/2007 Female 1/17/2008 Other Health Professional Sweden
Primary
Secondary
Tremor Other Serious 10/1/2007 Female 1/22/2008 Physician Germany
Primary
Concomitant
Pelvic Venous Thrombosis Life Threatening 9/10/2007 Female 209 lb 3/18/2008 Germany
Primary
Secondary
Concomitant
No Adverse Event 9/13/2007 Female 209 lb 3/18/2008 Germany
Primary
Secondary
Concomitant
Periorbital Oedema Other Serious 1/21/2008 Female 120 lb 4/1/2008 Physician Germany
Primary
Concomitant
Suicide Attempt Other Serious 62 Male 4/24/2008 Consumer Germany
Primary
Concomitant
Urinary Retention Other Serious 29 Male 176 lb 7/8/2008 United Kingdom
Primary
Secondary
Vision Blurred Other Serious 1/26/2009 3/2/2009 Physician United Kingdom
Primary
Concomitant
Therapeutic Response Unexpected With Drug Substitution Other Serious 8/25/2008 40 Female 155 lb 3/27/2009 Consumer United States
Primary
Concomitant
Skin Burning Sensation Other Serious 4/16/2009 Female 5/13/2009 Physician United States
Primary
Concomitant
Potentiating Drug Interaction Other Serious 51 6/8/2009 Pharmacist United Kingdom
Primary
Secondary
Concomitant
Epilepsy Other Serious 51 Female 6/26/2009 Consumer United Kingdom
Primary
Concomitant
Interacting
Potentiating Drug Interaction Other Serious 51 Female 6/25/2009 Other Health Professional United Kingdom
Primary
Concomitant
Potentiating Drug Interaction Other Serious 51 Female 7/2/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Potentiating Drug Interaction Other Serious 51 Female 6/30/2009 Pharmacist United Kingdom
Primary
Secondary
Concomitant
Potentiating Drug Interaction Other Serious 51 Female 7/6/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Stress Other Serious 51 Female 7/10/2009 Pharmacist United Kingdom
Primary
Secondary
Concomitant
Potentiating Drug Interaction Other Serious 51 7/20/2009 Pharmacist United Kingdom
Primary
Secondary
Concomitant
Weight Decreased Other Serious 11/1/2008 Female 102 lb 8/3/2009 Consumer United States
Primary
Concomitant
Pelvic Venous Thrombosis Life Threatening 9/10/2007 41 8/3/2009 Physician Germany
Primary
Secondary
Concomitant
Epilepsy Other Serious 51 8/3/2009 Pharmacist United Kingdom
Primary
Concomitant
Interacting
Nasal Operation Other Serious 51 Female 7/29/2009 Pharmacist United Kingdom
Primary
Secondary
Concomitant
Potentiating Drug Interaction Other Serious 51 Female 8/13/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Epilepsy Other Serious 51 Female 8/17/2009 Consumer United Kingdom
Primary
Concomitant
Interacting
Epilepsy Other Serious 51 Female 8/14/2009 Other Health Professional United Kingdom
Primary
Concomitant
Weight Decreased Other Serious 11/1/2008 Female 102 lb 8/24/2009 Consumer United States
Primary
Concomitant
Mood Altered Other Serious Female 95 lb 9/1/2009 Consumer United States
Primary
Concomitant
Treatment Noncompliance Other Serious 6/1/2009 56 Female 9/18/2009 Consumer United States
Primary
Concomitant
Treatment Noncompliance Other Serious 6/1/2009 56 Female 10/5/2009 Consumer United States
Primary
Concomitant
Mood Altered Other Serious Female 95 lb 10/9/2009 Consumer United States
Primary
Concomitant
Transaminases Increased Hospitalization 7/30/2009 Female 11/9/2009 Consumer Sweden
Primary
Secondary
Concomitant
Transaminases Increased Hospitalization 7/30/2009 Female 11/10/2009 Consumer Sweden
Primary
Secondary
Concomitant
Hypoaesthesia Other Serious 10/1/2009 60 Female 11/11/2009 Consumer United States
Primary
Secondary
Concomitant
Transaminases Increased Other Serious 1/1/2009 38 Female 11/11/2009 Other Health Professional Sweden
Primary
Secondary
Concomitant
Withdrawal Syndrome Other Serious 9/30/2009 Female 169 lb 11/12/2009 Other Health Professional United States
Primary
Concomitant
Treatment Failure Hospitalization 7/7/2009 Female 11/13/2009 Other Health Professional Sweden
Primary
Secondary
Concomitant
Product Substitution Issue Other Serious 10/1/2009 61 Female 12/18/2009 Consumer United States
Primary
Secondary
Concomitant
Nervous System Neoplasm Other Serious 12/1/2009 Female 160 lb 1/13/2010 Consumer United States
Primary
Concomitant
White Blood Cell Count Increased Hospitalization 9/9/2009 62 Female 215 lb 1/25/2010 Physician Austria
Primary
Secondary
Concomitant
Transaminases Increased Other Serious 1/1/2009 38 Female 1/28/2010 Other Health Professional Sweden
Primary
Secondary
Concomitant
Ileus Hospitalization 10/2/2009 62 Female 216 lb 1/29/2010 Other Health Professional Austria
Primary
Secondary
Concomitant
Visual Acuity Reduced Other Serious 8/1/2009 38 Female 2/17/2010 Consumer United States
Primary
Secondary
Concomitant
Pneumonia Primary Atypical Hospitalization 9/9/2009 62 Female 2/4/2010 Physician Austria
Primary
Secondary
Concomitant
Trigeminal Neuralgia Other Serious 1/1/2009 Female 2/19/2010 Consumer United States
Primary
Concomitant
Productive Cough 8/1/2009 49 Female 2/26/2010 Consumer United States
Primary
Concomitant
Drug Ineffective 9/1/2009 56 Female 2/26/2010 Consumer United States
Primary
Concomitant
White Blood Cell Count Decreased Other Serious 1/1/2010 Male 3/18/2010 Consumer United States
Primary
Secondary
Concomitant
Product Substitution Issue Other Serious 61 Female 130 lb 3/19/2010 Consumer United States
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 1/1/2010 Male 3/22/2010 Consumer United States
Primary
Secondary
Concomitant
Pyrexia Other Serious 25 Male 3/24/2010 Consumer United Kingdom
Primary
Concomitant
Knee Arthroplasty Hospitalization 3/15/2010 47 Female 4/6/2010 Consumer United States
Primary
Concomitant
Drug Level Increased Life Threatening 3/3/2010 40 Male 254 lb 4/14/2010 Other Health Professional United Kingdom
Primary
Concomitant
Interacting
Mood Altered Other Serious 7/1/2009 63 Female 146 lb 4/28/2010 Consumer United States
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 1/1/2010 58 Male 4/29/2010 Consumer United States
Primary
Secondary
Concomitant
Drug Level Increased Life Threatening 3/3/2010 40 Male 254 lb 5/3/2010 Other Health Professional United Kingdom
Primary
Concomitant
Interacting
White Blood Cell Count Decreased Other Serious 1/1/2010 58 Male 5/17/2010 Consumer United States
Primary
Secondary
Concomitant
Nausea Hospitalization 3/15/2010 47 Female 6/9/2010 Consumer United States
Primary
Concomitant
Ulcer Haemorrhage Other Serious 5/1/2010 48 Male 226 lb 7/1/2010 Consumer United States
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 1/1/2010 58 Male 7/16/2010 Consumer United States
Primary
Secondary
Concomitant
Urinary Retention Other Serious 29 Male 176 lb 7/21/2010 Other Health Professional United Kingdom
Primary
Secondary
Blister 8/13/2007 52 Male 205 lb 8/2/2010 Consumer United States
Primary
Concomitant
Urinary Retention Other Serious 29 Male 176 lb 8/17/2010 Other Health Professional United Kingdom
Primary
Secondary
White Blood Cell Count Decreased Other Serious 1/1/2010 58 Male 8/18/2010 Consumer United States
Primary
Secondary
Concomitant
Weight Bearing Difficulty Hospitalization 3/15/2010 47 Female 8/17/2010 Consumer United States
Primary
Concomitant
Transaminases Increased Other Serious 1/1/2009 38 Female 8/23/2010 Other Health Professional Sweden
Primary
Secondary
Concomitant
Paraparesis Hospitalization 11/4/2009 54 Female 110 lb 9/7/2010 Physician Germany
Primary
Concomitant
Weight Increased 10/30/2009 55 Female 198 lb 9/14/2010 Consumer United States
Primary
Concomitant
Dysphagia 1/1/2010 Female 9/14/2010 Pharmacist United States
Primary
Concomitant
Tinnitus 1/1/2007 50 Female 150 lb 9/14/2010 Consumer United States
Primary
Secondary
Concomitant
Interacting
Epilepsy Other Serious 51 Female 9/16/2010 Pharmacist United Kingdom
Primary
Concomitant
Interacting
Weight Decreased Other Serious 11/1/2008 57 Female 102 lb 9/16/2010 Consumer United States
Primary
Concomitant
Mood Altered Other Serious Female 95 lb 9/16/2010 Consumer United States
Primary
Concomitant
Withdrawal Syndrome Other Serious 9/30/2009 55 Female 169 lb 9/16/2010 Other Health Professional United States
Primary
Concomitant
Nervous System Neoplasm Other Serious 12/1/2009 61 Female 160 lb 9/16/2010 Consumer United States
Primary
Concomitant
Mood Altered Other Serious 7/1/2009 63 Female 146 lb 9/16/2010 Physician United States
Primary
Secondary
Concomitant
Drug Level Increased Life Threatening 3/3/2010 40 Male 254 lb 9/16/2010 Other Health Professional United Kingdom
Primary
Concomitant
Interacting
Urinary Retention Other Serious 29 Male 176 lb 9/16/2010 Other Health Professional United Kingdom
Primary
Secondary
Transaminases Increased Other Serious 1/1/2009 38 Female 9/16/2010 Other Health Professional Sweden
Primary
Secondary
Concomitant
Paraparesis Hospitalization 11/4/2009 54 Female 110 lb 9/17/2010 Physician Germany
Primary
Concomitant
Drug Screen Positive Female 9/17/2010 Pharmacist United States
Primary
Concomitant
Muscular Weakness Hospitalization 1/1/2010 63 Female 10/6/2010 Consumer Canada
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 1/1/2010 58 Male 10/8/2010 Consumer United States
Primary
Secondary
Concomitant
Weight Bearing Difficulty Hospitalization 3/15/2010 47 Female 11/5/2010 Physician United States
Primary
Concomitant
Weight Bearing Difficulty Hospitalization 3/15/2010 47 Female 12/6/2010 Physician United States
Primary
Concomitant
Epilepsy Other Serious 51 8/3/2009 Pharmacist United Kingdom
Primary
Concomitant
Interacting
Urinary Retention Other Serious 29 Male 176 lb 7/21/2010 Other Health Professional United Kingdom
Primary
Secondary
Transaminases Increased Other Serious 1/1/2009 38 Female 8/23/2010 Other Health Professional Sweden
Primary
Secondary
Concomitant
Weight Decreased Other Serious 11/1/2008 57 Female 102 lb 8/24/2009 Consumer United States
Primary
Concomitant
Mood Altered Other Serious Female 95 lb 10/9/2009 Consumer United States
Primary
Concomitant
Withdrawal Syndrome Other Serious 9/30/2009 55 Female 169 lb 11/12/2009 Other Health Professional United States
Primary
Concomitant
Nervous System Neoplasm Other Serious 12/1/2009 61 Female 160 lb 1/13/2010 Consumer United States
Primary
Concomitant
Mood Altered Other Serious 7/1/2009 63 Female 146 lb 4/28/2010 Consumer United States
Primary
Secondary
Concomitant
Drug Level Increased Life Threatening 3/3/2010 40 Male 254 lb 5/3/2010 Other Health Professional United Kingdom
Primary
Concomitant
Interacting
Renal Failure Acute Hospitalization 5/15/2010 47 Female 168 lb 6/7/2010 Pharmacist United States
Primary
Concomitant
Pain In Extremity 10/16/2010 12/23/2010 Physician United States
Primary
Concomitant
Visual Impairment Hospitalization Male 12/28/2010 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Visual Impairment Hospitalization Male 12/20/2010 Consumer United Kingdom
Primary
Secondary
Concomitant
Drug Dispensing Error Hospitalization Male 1/6/2011 Consumer United Kingdom
Primary
Secondary
Concomitant
Nausea Other Serious Male 1/6/2011 Consumer United Kingdom
Primary
Secondary
Feeling Drunk Hospitalization 6/1/2010 Male 1/6/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Obstruction Other Serious 1/1/2010 58 Male 166 lb 1/10/2011 Consumer United States
Primary
Secondary
Concomitant
Syncope Hospitalization Male 1/13/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Abnormal Dreams Hospitalization Male 1/4/2011 United Kingdom
Primary
Secondary
Concomitant
Visual Impairment Hospitalization Male 1/4/2011 Consumer United Kingdom
Primary
Secondary
Concomitant
Psychotic Disorder Hospitalization 9/10/2010 65 Female 106 lb 1/14/2011 Physician United States
Primary
Secondary
Concomitant
Convulsion Other Serious 1/6/2011 53 Male 172 lb 1/19/2011 Other Health Professional United States
Primary
Concomitant
Hypersensitivity 1/1/2005 48 Female 150 lb 1/20/2011 Consumer United States
Primary
Secondary
Concomitant
Interacting
Syncope Hospitalization Male 1/10/2011 United Kingdom
Primary
Secondary
Concomitant
Mass Other Serious 1/1/2010 63 Female 1/25/2011 Consumer Canada
Primary
Secondary
Concomitant
Off Label Use Hospitalization 9/10/2010 65 Female 106 lb 1/31/2011 Physician United States
Primary
Secondary
Concomitant
Psychotic Disorder Hospitalization 9/10/2010 65 Female 107 lb 2/2/2011 Physician United States
Primary
Secondary
Concomitant
Drug Screen Positive Hospitalization 9/10/2010 65 Female 106 lb 2/3/2011 Physician United States
Primary
Concomitant
Urticaria 52 Female 2/28/2011 Consumer United States
Primary
Concomitant
Psychotic Disorder Hospitalization 9/10/2010 65 Female 107 lb 3/4/2011 Other Health Professional United States
Primary
Secondary
Concomitant
Drug Level Changed Other Serious 40 Male 3/10/2011 Physician United Kingdom
Primary
Concomitant
Psychotic Disorder Hospitalization 9/10/2010 65 Female 106 lb 1/31/2011 Other Health Professional United States
Primary
Secondary
Concomitant
Optic Atrophy Disability 1/1/2011 35 Male 172 lb 4/8/2011 Consumer Germany
Primary
Secondary
Visual Acuity Reduced Disability 1/1/2011 35 Male 172 lb 4/12/2011 Consumer Germany
Primary
Secondary
Myoclonus Other Serious 1/1/2010 24 Female 4/13/2011 Physician Croatia (Local Name: Hrvatska)
Primary
Secondary
Partial Seizures Other Serious 1/1/2007 19 Male 5/5/2011 Physician Germany
Primary
Secondary
Concomitant
Asterixis Death 4/29/2011 49 Male 134 lb 6/10/2011 Consumer United States
Primary
Secondary
Concomitant
Urticaria Other Serious 1/1/2011 23 Female 6/10/2011 Consumer United States
Primary
Secondary
Concomitant
Syncope Hospitalization 4/29/2011 49 Male 134 lb 8/2/2011 Consumer United States
Primary
Secondary
Concomitant
Psychotic Disorder Hospitalization 9/10/2010 65 Female 106 lb 9/22/2011 Physician United States
Primary
Secondary
Concomitant
Euphoric Mood Other Serious 10/1/2009 49 Male 210 lb 10/12/2011 Consumer United States
Primary
Concomitant
Sedation Other Serious 7/1/2011 45 Female 172 lb 10/20/2011 Consumer Brazil
Primary
Concomitant
Myoclonus Other Serious 8/1/2011 Male 10/31/2011 Physician Switzerland
Primary
Concomitant

Drug Data